stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / NEO / Net Income

NeoGenomics, Inc. Net Income 2010–2025

NeoGenomics, Inc. (NEO) annual net income by fiscal year, computed from SEC filings.

Fiscal yearNet IncomeNet marginChange (YoY)
FY 2025$-108.03M-14.9%-37.2%
FY 2024$-78.73M-11.9%+10.5%
FY 2023$-87.97M-14.9%+39.0%
FY 2022$-144.25M-28.3%-1628.2%
FY 2021$-8.35M-1.7%-300.1%
FY 2020$4.17M0.9%-47.9%
FY 2019$8.01M2.0%+203.3%
FY 2018$2.64M1.0%+766.7%
FY 2017$-396,000-0.2%+93.6%
FY 2016$-6.14M-2.6%-142.3%
FY 2015$-2.54M-323.9%
FY 2014$1.13M-44.3%
FY 2013$2.03M+3027.7%
FY 2012$65,000+105.5%
FY 2011$-1.18M+64.4%
FY 2010$-3.30M

Source: NeoGenomics, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for NeoGenomics, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

NeoGenomics, Inc. — frequently asked questions

What is NeoGenomics, Inc.'s net income?

NeoGenomics, Inc. (NEO) reported net income of $-108.03M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from NeoGenomics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More NEO financial history

Full NEO fundamentals page → · All 1,500+ companies →